Since our findings support previous associations of HOXA9 and ISL1 methylation with tumour characteristics and behaviour[9,13], we appraised potential clinical correlates of HOXA9 and ISL1 methylation, including their prognostic potential. This evidence concerns the gene HOXA9 and neoplasm.